Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01814553
Title ADAM-Afatinib Diarrhea Assessment and Management
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements No
Sponsors Boehringer Ingelheim
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
1200.167.01009 Boehringer Ingelheim Investigational Site Santa Rosa California United States Details
1200.167.01020 Boehringer Ingelheim Investigational Site Orlando Florida United States Details
1200.167.01018 Boehringer Ingelheim Investigational Site Port St. Lucie Florida United States Details
1200.167.01012 Boehringer Ingelheim Investigational Site St. Petersburg Florida United States Details
1200.167.01007 Boehringer Ingelheim Investigational Site Skokie Illinois United States Details
1200.167.01008 Boehringer Ingelheim Investigational Site Skokie Illinois United States Details
1200.167.01001 Boehringer Ingelheim Investigational Site Morristown New Jersey United States Details
1200.167.01014 Boehringer Ingelheim Investigational Site Corvallis Oregon United States Details
1200.167.01002 Boehringer Ingelheim Investigational Site Chattanooga Tennessee United States Details
1200.167.01006 Boehringer Ingelheim Investigational Site Chattanooga Tennessee United States Details
1200.167.01005 Boehringer Ingelheim Investigational Site Nashville Tennessee United States Details
1200.167.01003 Boehringer Ingelheim Investigational Site Richmond Virginia United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field